Parvovirus B19 Antibodies in Patients with Haemophilia A

• References

• 1 Große-Bley A, Eis-Hübinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE. Serological and virological markers of human Parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 1994; 72: 503-507
• 2 Mortimer PP, Luban NL C, Kelleher JF, Cohen BJ. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983; 2: 482-484
• 3 Bartolomei CorsiO, Azzi A, Morfini M, Fanci R, Rossi FerriniP. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-170
• 4 Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991; 23: 675-679
• 5 Azzi A, Ciappi S, Zakvrzewska K, Morfini M, Mariani G, Mannucci PM. Human parvovirus B19 infection in hemophiliacs first infused with two- high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 30: 228-230
• 6 Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M. Eliminating parvovirus B19 from blood products. Lancet 1994; 343: 798 (Letter)
• 7 Brown CS, Van BusselM, Wassenaar AL, Van Elsacker-Niele AM, Weiland HT, Salimans MM. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods 1990; 29: 53-62